CNS vs FSK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 27, 2026

CNS

57.6
AI Score
VS
CNS Wins

FSK

35.8
AI Score

Investment Advisor Scores

CNS

58score
Recommendation
HOLD

FSK

36score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS FSK Winner
Forward P/E 22.5734 6.4641 FSK
PEG Ratio 2.017 3.2724 CNS
Revenue Growth 12.2% -24.0% CNS
Earnings Growth 31.9% 33.8% FSK
Tradestie Score 57.6/100 35.8/100 CNS
Profit Margin 28.8% -38.6% CNS
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL CNS

Relative Price Performance (Last 90 Days)

CNS 1M: +7.7% · 3M: +22.1% FSK 1M: +6.3% · 3M: -4.0%

Current Technical Phase

CNS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.5% over 20 days), RSI 66

RSI (14): 66.0 · Price: $84.63

FSK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.1 · Price: $11.09

Fundamentals Snapshot

Metric CNS FSK
Market Cap
Forward P/E 21.8 7.2
Trailing P/E 25.3
Revenue (TTM)
Revenue Growth 0.1% -0.2%
Gross Margin 0.5% 1.0%
Operating Margin 0.3% 0.7%
EPS 3.25 -1.96
Dividend Yield 0.03% 0.22%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.